Related Experiment Video
Updated: Apr 21, 2026
Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound
Published on: November 21, 2023
National consensus on management of peptic ulcer bleeding in Denmark 2014
Stig Borbjerg Laursen1, Henrik Stig Jørgensen, Ove B Schaffalitzky de Muckadell
1Department of Gastroenterology S, Odense University Hospital, DK-5000, Odense C, Denmark. sdm@ouh.regionsyddanmark.dk.
Insights
This guideline provides recommendations for managing peptic ulcer bleeding, emphasizing early resuscitation and timely endoscopy. It advises restrictive transfusion policies and highlights effective endoscopic hemostasis techniques for better patient outcomes.
Area of Science:
- Gastroenterology
- Hepatology
- Clinical Management
Background:
- Peptic ulcer bleeding is a significant clinical challenge requiring standardized management protocols.
- Existing guidelines may not fully address the nuances of resuscitation, transfusion, and endoscopic interventions.
- The Danish Society of Gastroenterology and Hepatology identified a need for updated national recommendations.
Purpose of the Study:
- To establish a national guideline for the effective management of peptic ulcer bleeding.
- To provide evidence-based recommendations for resuscitation, endoscopic treatment, and pharmacological management.
- To optimize patient care pathways, reduce rebleeding rates, and shorten hospital stays.
Main Methods:
- A comprehensive review of published studies up to June 2014 was conducted.
- Quality of evidence and strength of recommendations were systematically graded.
- The guideline was developed and approved by the Danish Society of Gastroenterology and Hepatology.
Main Results:
- Early and efficient resuscitation is crucial for managing peptic ulcer bleeding.
- Restrictive blood transfusion policies are recommended for stable patients.
- Endoscopy within 24 hours (or 12 hours for suspected serious bleeding) improves outcomes.
- Endoscopic hemostasis using clips, thermocoagulation, or combined therapies is effective for high-risk lesions.
- Intravenous high-dose proton pump inhibitor (PPI) therapy for 72 hours post-hemostasis is advised, though evidence is debated.
- Secondary cardiovascular prophylaxis with acetylsalicylic acid (ASA) should commence within 24 hours of endoscopy.
- Combination therapy of ASA and PPI is preferred over clopidogrel monotherapy for certain patients.
- Low-risk patients (Glasgow Blatchford score ≤ 1) may be managed as out-patients.
Conclusions:
- The guideline offers a structured approach to peptic ulcer bleeding management, integrating resuscitation, endoscopy, and pharmacotherapy.
- Timely endoscopic intervention and appropriate pharmacological strategies, including PPIs and antiplatelet agents, are key to successful treatment.
- The recommendations aim to improve patient outcomes, reduce healthcare resource utilization, and guide clinical decision-making for both high- and low-risk patients.
Description:
The Danish Society of Gastroenterology and Hepatology have compiled a national guideline for the management of peptic ulcer bleeding. Sources of data included published studies up to June 2014. Quality of evidence and strength of recommendations have been graded. The guideline was approved by the Danish Society of Gastroenterology and Hepatology September 4, 2011. The current version is revised June 2014.
Recommendations:
RECOMMENDATIONS emphasize the importance of early and efficient resuscitation. Use of a restrictive blood transfusion policy is recommended in haemodynamically stable patients without serious ischaemic disease. Endoscopy should generally be performed within 24 hours, reducing operation rate, rebleeding rate and duration of in-patient stay. When serious ulcer bleeding is suspected and blood found in gastric aspirate, endoscopy within 12 hours will result in faster discharge and reduced need for transfusions. Endoscopic hemostasis remains indicated for high-risk lesions. Hemoclips, thermocoagulation, and epinephrine injection are effective in achieving endoscopic hemostasis. Use of endoscopic monotherapy with epinephrine injection is not recommended. Intravenous high-dose proton pump inhibitor (PPI) therapy for 72 hours after successful endoscopic hemostasis is recommended even though the evidence is questionable. Although selected patients can be discharged promptly after endoscopy, high-risk patients should be hospitalized for at least three days after endoscopic hemostasis. Patients with peptic ulcer bleeding who require secondary cardiovascular prophylaxis should start receiving acetylsalicylic acid (ASA) within 24 hours from primary endoscopy. Patients in need of continued treatment with ASA or a nonsteroidal anti-inflammatory drug should be put on prophylactic treatment with PPI at standard dosage. The combination of 75 mg ASA and PPI should be preferred to monotherapy with clopidogrel in patients needing anti-platelet therapy on the basis of indications other than coronary stents. Low-risk patients without clinical suspicion of peptic ulcer bleeding who have a Glasgow Blatchford score ≤ 1 can be offered out-patient care, unless hospital admission is required for other reasons.
